Replimune Group Statistics
Total Valuation
Replimune Group has a market cap or net worth of $199.83 million. The enterprise value is $7.03 million.
Important Dates
The next estimated earnings date is Thursday, May 21, 2026, before market open.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Replimune Group has 82.57 million shares outstanding. The number of shares has increased by 22.99% in one year.
| Current Share Class | 82.57M |
| Shares Outstanding | 82.57M |
| Shares Change (YoY) | +22.99% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 76.62% |
| Float | 62.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.36.
| Current Ratio | 5.60 |
| Quick Ratio | 5.43 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.70 |
Financial Efficiency
Return on equity (ROE) is -90.88% and return on invested capital (ROIC) is -47.94%.
| Return on Equity (ROE) | -90.88% |
| Return on Assets (ROA) | -43.24% |
| Return on Invested Capital (ROIC) | -47.94% |
| Return on Capital Employed (ROCE) | -114.36% |
| Weighted Average Cost of Capital (WACC) | 8.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$657,313 |
| Employee Count | 479 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -418,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.59% in the last 52 weeks. The beta is 0.74, so Replimune Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -72.59% |
| 50-Day Moving Average | 6.43 |
| 200-Day Moving Average | 7.16 |
| Relative Strength Index (RSI) | 32.08 |
| Average Volume (20 Days) | 10,209,040 |
Short Selling Information
The latest short interest is 16.34 million, so 19.78% of the outstanding shares have been sold short.
| Short Interest | 16.34M |
| Short Previous Month | 16.23M |
| Short % of Shares Out | 19.78% |
| Short % of Float | 25.97% |
| Short Ratio (days to cover) | 10.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -324.22M |
| Pretax Income | -315.27M |
| Net Income | -314.85M |
| EBITDA | -318.88M |
| EBIT | -324.22M |
| Earnings Per Share (EPS) | -$3.44 |
Full Income StatementBalance Sheet
The company has $269.14 million in cash and $76.35 million in debt, with a net cash position of $192.79 million or $2.33 per share.
| Cash & Cash Equivalents | 269.14M |
| Total Debt | 76.35M |
| Net Cash | 192.79M |
| Net Cash Per Share | $2.33 |
| Equity (Book Value) | 210.54M |
| Book Value Per Share | 2.64 |
| Working Capital | 230.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$277.91 million and capital expenditures -$5.35 million, giving a free cash flow of -$283.27 million.
| Operating Cash Flow | -277.91M |
| Capital Expenditures | -5.35M |
| Depreciation & Amortization | 5.34M |
| Net Borrowing | -701,000 |
| Free Cash Flow | -283.27M |
| FCF Per Share | -$3.43 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Replimune Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.99% |
| Shareholder Yield | -22.99% |
| Earnings Yield | -157.56% |
| FCF Yield | -141.76% |
Analyst Forecast
The average price target for Replimune Group is $5.67, which is 134.30% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.67 |
| Price Target Difference | 134.30% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
